NCT07114562View on ClinicalTrials.gov

Evaluation of the Safety and Performance of Epicare for the Treatment of Periorbital Wrinkles

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 30, 2025

Primary Completion Date

October 30, 2026

Study Completion Date

November 30, 2026

Conditions
Wrinkle
Interventions
DEVICE

Epicare

All participants will receive treatment with the Epicare fractional nano-thulium (Tm:YAP, 1938 nm) laser device for the reduction of periorbital wrinkles.

All Listed Sponsors
lead

Laser team Ltd

INDUSTRY

NCT07114562 - Evaluation of the Safety and Performance of Epicare for the Treatment of Periorbital Wrinkles | Biotech Hunter | Biotech Hunter